Jill L. Schwartz - Concepedia

Author

Jill L. Schwartz

Also Known As

, J L Schwartz, J SCHWARTZ, J Schwartz, J. Schwartz, J.L. Schwartz, Jill L Schwartz, Jill L. Schwartz, Jill Schwartz, McCallister, Scott

126

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Eastern Virginia Medical School Contraception Research and Development University of Pittsburgh Family Health International 360 Magee-Womens Research Institute

About

Jill L. Schwartz is an author at Eastern Virginia Medical School specializing in medicine, obstetrics, and reproductive health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	896
2	Public Health	11	11	442
3	Social Sciences	4	4	138
4	Language Studies	1	1	65
5	Natural Sciences	1	1	55

Jill L. Schwartz

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women Jeanne Marrazzo, Gita Ramjee, Barbra A. Richardson, New England Journal of Medicine	2015	1.3K
<i>In Vitro</i> and <i>in Vivo</i> Characterization of a Potential Universal Placebo Designed for Use in Vaginal Microbicide Clinical Trials Deborah Tien, Roger L. Schnaare, Feirong Kang, AIDS Research and Human Retroviruses	2005	177
The Tablets, Ring, Injections as Options (<scp>TRIO</scp>) study: what young African women chose and used for future <scp>HIV</scp> and pregnancy prevention Ariane van der Straten, Kawango Agot, Khatija Ahmed, Journal of the International AIDS Society Contraceptive UseOral ContraceptiveContraceptive DiscontinuationYoung African WomenGynecology	2018	109
A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel Jill L. Schwartz, Wes Rountree, Angela D. M. Kashuba, PLoS ONE	2011	96
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial Sinéad Delany‐Moretlwe, Carl Lombard, Deborah Baron, The Lancet Infectious Diseases Sexual HealthPhase 3Treatment And PreventionSouth AfricaAntiviral Therapy	2018	94
Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study Christine K. Mauck, Debra H. Weiner, Susan A. Ballagh, Contraception Biopolymer GelCellulose Sulfate GelColposcopy StudyWound HealingBiomedical Engineering	2001	91
Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity Andrea R. Thurman, Thomas Kimble, Betsy C. Herold, AIDS Research and Human Retroviruses	2015	89
Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study Jill L. Schwartz, Christine Mauck, Jaim-Jou Lai, Contraception Biopolymer GelBiomanufacturingAcceptability StudyFourteen-day SafetyBiomedical Engineering	2006	84
Tenofovir-Based Preexposure Prophylaxis for HIV Infection Among African Women Jeanne Marrazzo, Gita Ramjee, Barbra A. Richardson, Obstetrical & Gynecological Survey PharmacotherapyAntiviral DrugContraceptionPreventive MedicineHiv/aids Counselling	2015	66
Compound word effects differ in reading, on-line naming, and delayed naming tasks Albrecht W. Inhoff, Deborah Briihl, Jill L. Schwartz Memory & Cognition Cognitive LinguisticsCognitive ScienceSemantic ProcessingComputational LinguisticsLanguage Acquisition	1996	65

Page 1